97 related articles for article (PubMed ID: 1855907)
1. Characterization of activation and deactivation pathways of 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes.
Liu L; Alaoui-Jamali MA; el Alami N; Castonguay A
IARC Sci Publ; 1991; (105):510-5. PubMed ID: 1855907
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes.
Liu LL; Alaoui-Jamali MA; el Alami N; Castonguay A
Cancer Res; 1990 Mar; 50(6):1810-6. PubMed ID: 2306734
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.
Richter E; Engl J; Friesenegger S; Tricker AR
Chem Res Toxicol; 2009 Jun; 22(6):1008-17. PubMed ID: 19408892
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA.
Lacroix D; Desrochers M; Castonguay A; Anderson A
Carcinogenesis; 1993 Aug; 14(8):1639-42. PubMed ID: 8353848
[TBL] [Abstract][Full Text] [Related]
5. Comparison of DNA alkali-labile sites induced by 4-(methylnitrosamino)-1(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)butanal in rat hepatocytes.
Demkowicz-Dobrzanski K; Castonguay A
Carcinogenesis; 1991 Nov; 12(11):2135-40. PubMed ID: 1934300
[TBL] [Abstract][Full Text] [Related]
6. Intestinal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats: Sex difference, inducibility and inhibition by phenethylisothiocyanate.
Schulze J; Malone A; Richter E
Carcinogenesis; 1995 Aug; 16(8):1733-40. PubMed ID: 7634397
[TBL] [Abstract][Full Text] [Related]
7. Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen.
Hecht SS; Young R; Chen CB
Cancer Res; 1980 Nov; 40(11):4144-50. PubMed ID: 7471055
[TBL] [Abstract][Full Text] [Related]
8. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue.
Doerr-O'Rourke K; Trushin N; Hecht SS; Stoner GD
Carcinogenesis; 1991 Jun; 12(6):1029-34. PubMed ID: 2044181
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the metabolism and genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes by (+)-catechin.
Liu L; Castonguay A
Carcinogenesis; 1991 Jul; 12(7):1203-8. PubMed ID: 2070485
[TBL] [Abstract][Full Text] [Related]
10. Modulation by glutathione of DNA strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its aldehyde metabolites in rat hepatocytes.
Demkowicz-Dobrzanski K; Castonguay A
Carcinogenesis; 1992 Aug; 13(8):1447-54. PubMed ID: 1499096
[TBL] [Abstract][Full Text] [Related]
11. Cell specificity for the pulmonary metabolism of tobacco-specific nitrosamines in the Fischer rat.
Belinsky SA; White CM; Trushin N; Hecht SS
Carcinogenesis; 1989 Dec; 10(12):2269-74. PubMed ID: 2591016
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver.
Schrader E; Hirsch-Ernst KI; Richter E; Foth H
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):336-43. PubMed ID: 9550307
[TBL] [Abstract][Full Text] [Related]
13. DNA single-strand breaks and toxicity induced by 4-(methyl-nitrosamino)-1-(3- pyridyl)-1-butanone or N-nitrosodimethylamine in hamster and rat liver.
Jorquera R; Castonguay A; Schuller HM
Carcinogenesis; 1994 Feb; 15(2):389-94. PubMed ID: 8313533
[TBL] [Abstract][Full Text] [Related]
14. The profile of urinary metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats is determined by its pulmonary metabolism.
Schneider T; Frei E; Wiessler M
Chem Biol Interact; 1999 Apr; 118(3):247-66. PubMed ID: 10362230
[TBL] [Abstract][Full Text] [Related]
15. Use of precision-cut tissue slices in organ culture to study metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by hamster lung, liver and kidney.
Richter E; Friesenegger S; Engl J; Tricker AR
Toxicology; 2000 Apr; 144(1-3):83-91. PubMed ID: 10781874
[TBL] [Abstract][Full Text] [Related]
16. 32P-postlabelling analysis of DNA-adducts formed by 4-(N-carbethoxy-N-nitrosamino)-(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)- butanal.
Schmeiser HH; Castonguay A; Wiessler M
IARC Sci Publ; 1993; (124):207-10. PubMed ID: 8225486
[TBL] [Abstract][Full Text] [Related]
17. Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK.
Murphy SE; Nunes MG; Hatala MA
Chem Biol Interact; 1997 Mar; 103(3):153-66. PubMed ID: 9134006
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the tobacco specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.
Hecht SS; Chen CB; Young R; Lin D; Hoffmann D
IARC Sci Publ; 1980; (31):755-65. PubMed ID: 7228296
[TBL] [Abstract][Full Text] [Related]
19. Formation of NADP(H) analogs of tobacco-specific nitrosamines in rat liver and pancreatic microsomes.
Peterson LA; Ng DK; Stearns RA; Hecht SS
Chem Res Toxicol; 1994; 7(5):599-608. PubMed ID: 7841337
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites.
Hecht SS; Trushin N; Reid-Quinn CA; Burak ES; Jones AB; Southers JL; Gombar CT; Carmella SG; Anderson LM; Rice JM
Carcinogenesis; 1993 Feb; 14(2):229-36. PubMed ID: 8435864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
